Cath labs or cardiac catheterization laboratories in hospitals conduct both diagnostic and therapeutic procedures. These laboratories are used to conduct normal procedures such as the monitoring of blood flow and heart pressure. Advances in catheterization technology such as robot-assisted catheterization for cardiac catheterization have advanced the digital imaging system. One driver in market is growing focus on clinical trials. Vendors are using advanced technologies to develop innovative ablation catheters. They invest in R&D to develop cost-effective and efficient devices and lower manufacturing costs. Many of these devices are awaiting approval across different countries.
Scope of the Report:This report focuses on the Cardiac Ablation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
One of the primary drivers for this market is the rise in the adoption ofÊminimally invasive proceduresÊwith improvedÊmedical imaging. Medical facilities across the world are shifting toward minimally invasive procedures, which involve the use ofÊradiotherapyÊandÊimaging technologiesÊand expand the treatment options for cardiac diseases such asÊatrial fibrillation. Through imaging, the anatomy of the heart can be studied, which helps the physician diagnose and conduct cardiac ablation procedure. For instance,Êfluoroscopy imagingÊis used for most of the complex atrial fibrillation procedures; fluoroscopy imaging modality is used to guide the catheter and improve the surgical outcome. These advantages ofÊmedical imagingÊare expected to propel growth in the globalÊcardiac ablation marketÊduring the forecast period.
The emerging markets including China, India, Brazil, and Mexico have become attractive destinations for companies engaged in the development, manufacturing, and distribution of cardiac ablation products. A number of factors such as success of microwave ablation procedure in clinical trials to treat atrial fibrillation, growing adoption of ablation in CVS disease treatment, and growing market penetration of ablation product manufacturers across developing countries are offering high growth opportunities for the playersÕ active in the Cardiac ablation market.
The worldwide market for Cardiac Ablation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2025, from xx million US$ in 2020, according to a new study.
Market Segment by Manufacturers, this report covers Boston Scientific
Medtronic
St. Jude Medical
AblaCor
Advanced Cardiac Therapeutics
AngioDynamics
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers Irreversible Electroporation
HIFU
MRgFUS
Market Segment by Applications, can be divided into Cardiac Arrhythmia
Atrial Fibrillation
Tachycardia
Open Surgery
There are 15 Chapters to deeply display the global Cardiac Ablation market.
Chapter 1, to describe Cardiac Ablation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cardiac Ablation, with sales, revenue, and price of Cardiac Ablation, in 2018 and 2019;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2018 and 2019;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiac Ablation, for each region, from 2015 to 2020;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2015 to 2020;
Chapter 12, Cardiac Ablation market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025;
Chapter 13, 14 and 15, to describe Cardiac Ablation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
